Blockchain Registration Transaction Record

FELIQS Secures $9M to Advance Pediatric Retinal Disease Treatment

FELIQS Corporation raises $9M to accelerate FLQ-101, a novel treatment for retinopathy of prematurity, marking a leap forward in pediatric retinal disease care.

FELIQS Secures $9M to Advance Pediatric Retinal Disease Treatment

This news is significant because it highlights a major advancement in the treatment of retinopathy of prematurity, a condition that can lead to blindness in premature infants. The development of FLQ-101 represents hope for families and healthcare providers dealing with this challenging condition, offering a potential solution where few exist. The investment and regulatory support underscore the therapy's potential to fill a critical gap in neonatal care, promising to improve outcomes for vulnerable newborns worldwide.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0xf588f6efc1e0ac9104376763a2239145ec24f49cdc9c743f96bbc5659d9a3ac6
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintoxenz1mM-c4377ae31fd4ce4d9e1b0a56181965de